Multiple system organ failure (MSOF) has been described Methods and results as the sequential failure of the lungs, liver, kidney and other After obtaining approval from the Hospital Ethics Commitvital organ systems after a variety of acute pathological tee and written informed consent from relatives, 50 patients, conditions, such as sepsis, multiple trauma, haemorrhagic aged 21-79 yr (median 63 yr), were recruited after ICU shock or pancreatitis. 1 Although the mechanisms involved admission over a 6-month period. Patients suffering from in the development of this syndrome are not entirely clear, chronic organ insufficiency before this hospital admission it is proposed that MSOF after trauma or surgery results according to APACHE II guidelines, or those with a from a generalized inflammatory reaction with activation predicted ICU stay of less than 24 h were excluded. of leucocytes and release of free radicals and other medi-APACHE II scores were determined 24 h after admission ators, such as cytokines, from these cells. 2 to the ICU. To assess the degree of organ dysfunction, a The optimal use of intensive care unit (ICU) resources modified daily multiple organ dysfunction score (MODS) and an accurate method of predicting the outcome of the was determined. 7 critically ill has been the aim of many studies over several Fresh urine samples (approximately 15 ml) were years. 3 Earlier identification of patients most at risk of collected at 6 hourly intervals from the urinary catheter serious complications and adverse outcomes would mean and stored at 4°C until analysis of microalbumin by that they can be targeted more accurately with potentially automated immunoturbidimetry on a Beckman Synchron expensive clinical interventions.
CX-7. Urine creatinine was estimated on a Beckman Microalbuminuria has been identified as showing promise Synchron CX-7 by a modified Jaffé rate method with as a predictor of outcome, 4 but requires application in a alkaline picrate. Results are expressed as the microalbumin mixed population; this has been addressed in our study. (mg):creatinine (mmol) ratio to correct for variations in Several studies have described a rapid increase in urine urine flow rate; for the purpose of this study, a ratio of albumin (microalbumin) excretion in acute inflammatory 3 mg mmol -1 was selected as the cut-off. Inter-assay conditions, which appears to be related to systemic vascular precision was 7% for a microalbumin:creatinine (M:Cr) damage exemplified by capillary leak syndrome. 5 6 ratio of 7.5 mg mmol -1 . The aim of our study was to assess the practicability of Differences in variables between survivors and nonmeasurement of microalbuminuria in critically ill patients survivors were compared using the non-parametric MannWhitney U test with PϽ0.05 considered to be statistically as a predictor of outcome.
Comment
In this pilot study, we examined a heterogeneous group of patients with a variety of clinical conditions, which accurately reflected patients admitted to a general ICU in the UK. This was considered advantageous, as any predictive test result must be applicable to all patients with a wide variety of diagnoses, not just small highly selected groups.
Increases in urinary albumin excretion were seen on admission to the ICU in both survivors and non-survivors and appeared to be quantitatively related to the degree of multiple organ failure, with the most microalbuminuria rapid prediction of outcome in critically ill patients, 6 h after admission to the ICU; this is much earlier than current clinical scoring systems can be used. A high sensitivity is significant. The relationship between M:Cr ratio and desirable as this selects those patients who are more likely survival was also explored using multiple logistic regres-to die and who may benefit from earlier more intensive sion (SPSS version 8.0 for Windows). Spearman rank treatment. 4 5 Calculation of the probability of death for correlation coefficients (r) were used to quantify the M:Cr ratios obtained in this study (Fig. 1) suggests that a correlation between variables.
rapid indication of outcome can be obtained within 6 h of Outcome was assessed according to patient hospital ICU admission. survival; 36 patients survived, while 14 died. Non-survivors In summary, the speed and magnitude of the renal were slightly older as a group (median 66 yr) than survivors permeability response to indirect injury and its association (median 58 yr; Pϭ0.12); 36% of survivors (13 of 36) were with outcome suggest that measurement of microalbuminufemale compared with 43% of non-survivors (six of 14). ria may have a role in the early identification of patients at Survivors had a slightly longer median stay (6 days) in the increased risk of developing MSOF, possibly leading to ICU compared with non-survivors (5 days), but this was death. As the number of patients studied was small, further not statistically significant (Pϭ0.19). studies in larger numbers of heterogeneous patients are The onset of microalbuminuria was rapid, with increased required to confirm this finding, validate the M:Cr cut-off urinary albumin excretion observed on admission to the and examine if measurement of microalbuminuria as an ICU, with marked differences between survivors and non-indirect measure of capillary leak may be useful as an early survivors, even 6 h after admission. Furthermore, the predictive indicator; these studies are currently underway. degree of microalbuminuria correlated with the admission Confirmation of these findings means that measurement APACHE II and day 1 MODS. Spearman correlation of urine microalbumin would provide a rapid, simple, coefficients between M:Cr after 6, 12 and 18 h with inexpensive test to identify patients who may benefit from APACHE II were 0.52, 0.59 and 0.54, respectively (all appropriate early therapeutic strategies which may prevent PϽ0.001) and with day 1 MODS were 0.43, 0.50 and 0.46 further capillary leak and hence the onset of MSOF and (all Pഛ0.002).
death. Logistic regression was used to model this situation using the M:Cr ratios at 6 h. The M:Cr ratio at 6 h was significantly different between survivors and non-survivors (chi-squareϭ Acknowledgement 5.6, dfϭ1, Pϭ0.02) and the relationship between M:Cr Financial support for this study was from Aintree Hospitals NHS Trust.
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collected at 12 or 18 h, and therefore this curve represents the relationship between M:Cr score and the probability of mortality between 6 and 18 h. Sensitivity and specificity References for 12 and 18 h were of a similar magnitude as those for 
